| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706522A1 Tetrazole derivatives having antihistaminic and antiallergic activity |
| 04/17/1996 | EP0706521A1 Novel imides |
| 04/17/1996 | EP0706513A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/17/1996 | EP0706508A1 Anti-atherosclerotic diaryl compounds |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0600952B1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 04/17/1996 | EP0558673B1 Retroviral protease inhibitors |
| 04/17/1996 | EP0493468B1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/17/1996 | CN1120845A 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
| 04/17/1996 | CN1120844A Phosphonomethyldipeptides |
| 04/17/1996 | CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 04/17/1996 | CN1120840A Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 04/17/1996 | CN1120549A Calcitonin analogue and use thereof |
| 04/17/1996 | CN1120532A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromones |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/16/1996 | US5508419 Substituted triazoles as angiotensin II inhibitors |
| 04/16/1996 | US5508408 Leukotriene antagonists |
| 04/16/1996 | US5508403 Enhances effects of antitumor agents |
| 04/16/1996 | US5508392 Use of vitamin D glycosides, vitamin D orthoester glycosides, vitamin D analog glycosides and vitamin D analog orthoester glycosides for the treatment of osteoporosis |
| 04/16/1996 | US5508311 Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents |
| 04/16/1996 | US5508306 Used for treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis |
| 04/16/1996 | US5508305 2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 04/16/1996 | US5508303 Hair-growing composition |
| 04/16/1996 | US5508299 Angiotensin converting enzyme inhibitor, arterial hypotensive agent; cardiovascular disorders |
| 04/16/1996 | US5508292 Administering anticoagulants to humans to treat atherosclerotic diseases; cardiovascular disorders |
| 04/16/1996 | US5508274 24R,25-dihydroxycholecalciferol to treat vitamin D resistant rickets |
| 04/16/1996 | US5508272 Compounds containing a fused bicycle ring and processes therefor |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES |
| 04/11/1996 | WO1996010568A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | WO1996010562A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2199621A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | CA2198382A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 04/11/1996 | CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705839A1 Imidobisphosphoric acids, process for their preparation and their use |
| 04/10/1996 | EP0705835A1 Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705819A1 1,4-Dihydropyridin-3,5-dicarboxylates and their use as selective K-channel modulators |
| 04/10/1996 | EP0705600A1 Use of 5-HT1F-receptor agonists for the treatment of migraine |
| 04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705272A1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | EP0705265A1 Novel chemical compounds having pde-iv inhibition activity |
| 04/10/1996 | EP0705259A1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
| 04/10/1996 | EP0705257A1 Aminoacid derivatives as no synthase inhibitors |
| 04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 04/10/1996 | EP0705245A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 04/10/1996 | EP0705100A1 Therapeutic substituted guanidines |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120314A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120304A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120039A Acylated aminoalknimidazoles and-triazoles |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1119940A Combination treatment for inhibiting bone loss |
| 04/09/1996 | US5506355 Method for preparing cyclic sulfamides and their use for the synthesis of HIV protease inhibitors |
| 04/09/1996 | US5506347 Lyxofuranosyl analogues of adenosine |
| 04/09/1996 | US5506270 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506237 Bicyclic nitrogen compounds |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506227 Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| 04/09/1996 | US5506133 Polypeptide |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5505943 Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 04/06/1996 | CA2159767A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| 04/04/1996 | WO1996020276A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | WO1996010035A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010034A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996010018A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 04/04/1996 | WO1996010013A1 Five membered heterocyclic compounds |
| 04/04/1996 | WO1996010012A1 Novel prostaglandin synthase inhibitors |
| 04/04/1996 | WO1996010011A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010003A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | WO1996009836A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009821A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009820A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009819A1 Inhibitor for bone resorption by osteoclast |
| 04/04/1996 | CA2275137A1 Processes for the preparation of (e)-2-(fluoromethylene)-4-(4-fluorophenyl)butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | CA2275136A1 Processes for the preparation of (e)-2-(fluoromethylene)-4-(4-fluorophenyl)butylamine and alkalimetal salts of diformylamide |
| 04/04/1996 | CA2208599A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | CA2201350A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201140A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |